Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692 · see citing works

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 601 · see citing works

Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail

Poljak, M., Marin, I. J., Seme, K., & Vince, A. (2002) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00187-7 · Cited by 166 · see citing works

Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results

Stevens, M. P., Garland, S. M., Rudland, E., Tan, J., Quinn, M. A., & Tabrizi, S. N. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02438-06 · Cited by 85 · see citing works

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening

Hesselink, A. T., Sahli, R., Berkhof, J., Snijders, P. J. F., van der Salm, M. L., Agard, D., Bleeker, M. C. G., & Heideman, D. A. M. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.01.009 · Cited by 61 · see citing works

Comparison of the anyplex II HPV28 assay with the hybrid capture 2 assay for the detection of HPV infection

Kwon, M.-J., Roh, K. H., Park, H., & Woo, H.-Y. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.01.015 · Cited by 55 · see citing works

HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia

Stevens, M. P., Garland, S. M., Tan, J., Quinn, M. A., Petersen, R. W., & Tabrizi, S. N. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21515 · Cited by 37 · see citing works

Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea

Jung, S., Lee, B., Lee, K. N., Kim, Y., & Oh, E.-J. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0117-oa · Cited by 33 · see citing works

Recommendations for the diagnosis of pediatric tuberculosis

for the Italian Pediatric TB Study Group, Chiappini, E., Vecchio, A. L., Garazzino, S., Marseglia, G. L., Bernardi, F., Castagnola, E., Tomà, P., Cirillo, D. M., Russo, C., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2507-6 · Cited by 32 · see citing works

Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

Latsuzbaia, A., Tapp, J., Nguyen, T., Fischer, M., Arbyn, M., Weyers, S., & Mossong, J. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.04.011 · Cited by 27 · see citing works

Comparison of the Roche Cobas® 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia

Phillips, S., Garland, S. M., Tan, J., Quinn, M. A., & Tabrizi, S. N. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.11.017 · Cited by 25 · see citing works

Cervical cancer prevention in Australia: Planning for the future

Saville, A. M. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21643 · Cited by 19 · see citing works

EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

Cornall, A. M., Poljak, M., Garland, S. M., Phillips, S., Machalek, D. A., Tan, J., Quinn, M. A., & Tabrizi, S. N. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2634-8 · Cited by 8 · see citing works

Comparison of the Roche Cobas® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus

Phillips, S., Cornall, A. M., Machalek, D. A., Garland, S. M., Bateson, D. J., Garefalakis, M., & Tabrizi, S. N. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2665-1 · Cited by 6 · see citing works

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

Oštrbenk, A., Xu, L., Arbyn, M., & Poljak, M. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01176-18 · Cited by 34 · see citing works

Cervico-Vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors

Rodrigues, L. L. S., Morgado, M. G., Sahasrabuddhe, V. V., De Paula, V. S., Oliveira, N. S., Chavez-Juan, E., Da Silva, D. M., Kast, W. M., Nicol, A. F., & Pilotto, J. H. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.08.004 · Cited by 29 · see citing works

hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing

Fitzpatrick, M. B., Mandishora, R. S. D., Katzenstein, D. A., McCarty, K., Weber, J., Sahoo, M. K., Manasa, J., Chirenje, Z. M., & Pinsky, B. A. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.022 · Cited by 27 · see citing works

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples

Bell, M., Verberckmoes, B., Devolder, J., Vermandere, H., Degomme, O., Guimarães, Y. M., Godoy, L. R., Ambrosino, E., Cools, P., & Padalko, E. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00081-23 · Cited by 22 · see citing works

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

Cornall, A. M., Poljak, M., Garland, S. M., Phillips, S., Machalek, D. A., Tan, J. H., Quinn, M. A., & Tabrizi, S. N. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.10.002 · Cited by 22 · see citing works

Distribution of HPV Subtypes in Diverse Anogenital and Oral Samples from Women and Correlation of Infections with Neoplasia of the Cervix

Bräutigam, K., Meier, S., Meneder, S., Proppe, L., Stroschein, K., Polack, S., Köster, F., Rody, A., & Baum, S. (2022) · Cancers · doi:10.3390/cancers14133136 · Cited by 18 · see citing works

Evaluation of the Anyplex II HPV28 Assay in the Detection of Human Papillomavirus in Archival Samples of Oropharyngeal Carcinomas

Rollo, F., Donà, M. G., Pichi, B., Pellini, R., Covello, R., & Benevolo, M. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2019-0199-oa · Cited by 18 · see citing works

Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection

Pino, M. L. D., Alonso, I., Rodríguez‐Trujillo, A., Bernal, S., Geraets, D. T., Guimerà, N., Torné, A., & Ordï, J. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.07.009 · Cited by 15 · see citing works

Human Papillomavirus genotype concordance between Anyplex II HPV28 and Linear array HPV genotyping test in anogenital samples

Coutlée, F., de Pokomandy, A., Burchell, A. N., El‐Zein, M., Mayrand, M., Rodrigues‐Coutlée, S., Money, D., Comète, É., McClymont, E., Rouleau, D., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27605 · Cited by 15 · see citing works

Analytical performance of a low‐cost multiplex polymerase chain reaction human papillomavirus genotyping assay for use in Sub‐Saharan Africa

Samwel, K., Kahesa, C., Mwaiselage, J. D., Gonzalez, D., West, J. T., Wood, C. A., Palefsky, J. M., & Angeletti, P. C. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25329 · Cited by 11 · see citing works

Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil

Rodrigues, L. L. S., Pilotto, J. H., Martinelli, K. G., Nicol, A. F., de Paula, V. S., Gheit, T., Oliveira, N. S. C., de Jesus, C. S., Sahasrabuddhe, V. V., Silva, D. M. D., et al. (2023) · Viruses · doi:10.3390/v15061328 · Cited by 7 · see citing works

Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening

Naegele, K., Bubendorf, L., Hirsch, H. H., & Leuzinger, K. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29649 · Cited by 6 · see citing works

EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol

van den Borst, E., Broeck, D. V., Sutter, P. D., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Weyers, S., Arbyn, M., Keer, S. V., & Latsuzbaia, A. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.08.018 · Cited by 6 · see citing works

Comparison of the Tellgenplex HPV DNA test with the PCR-reverse dot blot assay for human papillomavirus genotyping

Zhang, Z., Yao, Y., Li, N., Hu, L., & Li, Y.-H. (2018) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.225022 · Cited by 6 · see citing works

Interest of cytology combined with Xpert^®<scp>HPV</scp> and Anyplex^®<scp>II HPV</scp>28 Detection human papillomavirus (<scp>HPV</scp>) typing: differential profiles of anal and cervical <scp>HPV</scp> lesions in <scp>HIV</scp>‐infected patients on antiretroviral therapy

Nassereddine, H., Charpentier, C., Bucau, M., Joly, V, Bienvenu, L., Davitian, C., Abramowitz, L., Benabderrahmane, D., Kotelevets, L., Chastre, E., et al. (2018) · HIV Medicine · doi:10.1111/hiv.12661 · Cited by 6 · see citing works

Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review

Biazin, H. (2022) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114435 · Cited by 5 · see citing works

Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection

Godoy, L. R., El-Zein, M., Padalko, E. Y., Verberckmoes, B., Eenooghe, B. V., Vermandere, H., Dias, S., Gama, A., Vega, B., Neira, V. A., et al. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00200-25 · Cited by 5 · see citing works

Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil

Bandeira, I. C., Comerlato, J., Bessel, M., Fernandes, B. V., Mota, G., Villa, L. L., de Souza, F. M. A., Pereira, G. F. M., & Wendland, E. M. (2024) · PLOS ONE · doi:10.1371/journal.pone.0305122 · Cited by 3 · see citing works

Prevalence of Human Papillomavirus in Laryngeal Squamous Cell Carcinoma in Azerbaijan Population

Aliyev, A. J., Melikova, L. A., Bagirova, E. E., Akbarov, K., Aliyeva, A. M., & Quliyev, N. A. (2018) · Head and Neck Cancer Research · doi:10.21767/2572-2107.100024 · Cited by 3 · see citing works

Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens

Park, J. Y., Park, C. S., Jeong, J. Y., Kim, M., Yoo, S. H., Chong, G. O., Hong, D. G., & Park, J. Y. (2022) · Diagnostics · doi:10.3390/diagnostics12081855 · Cited by 1 · see citing works

Epidemiology of HPV infection in Ukraine

Sukhanova, A. A., Сідорова, І. В., Сиротинська, Г. І., & Бурка, О. А. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.32.39-44

EVALUATION OF A HUMAN PAPILLOMAVIRUS GENOTYPING ASSAY FOR CERVICAL CANCER SCREENING IN TANZANIA

kapie, K. (2018) · Lincoln (University of Nebraska)

Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus

Pasquier, C., Sauné, K., Raymond, S., Boisneau, J., Courtade, M., & Izopet, J. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.08.022 · Cited by 9 · see citing works

EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

Cornall, A. M., Poljak, M., Garland, S. M., Phillips, S., Machalek, D. A., Tan, J., Quinn, M. A., & Tabrizi, S. N. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2634-8 · Cited by 8 · see citing works

Comparison of the anyplex II HPV28 assay with the hybrid capture 2 assay for the detection of HPV infection

Kwon, M.-J., Roh, K. H., Park, H., & Woo, H.-Y. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.01.015 · Cited by 55 · see citing works

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening

Hesselink, A. T., Sahli, R., Berkhof, J., Snijders, P. J. F., van der Salm, M. L., Agard, D., Bleeker, M. C. G., & Heideman, D. A. M. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.01.009 · Cited by 61 · see citing works

Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.

Baasland, I., Romundstad, P. R., Eide, M. L., & Jonassen, C. M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210997 · Cited by 33 · see citing works